Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Oncolytics Biotech Inc > Its that time of year again....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5340)
•••
Comment by Noteableon Oct 31, 2022 11:52am
147 Views
Post# 35060264

RE:RE:RE:Its that time of year again....

RE:RE:RE:Its that time of year again....Well Hcallahan you admitted to being Mattsafford9 on the ONCY Stocktwits board before deleting that post.  Now lay out your case as you have claimed below and we don't want to hear about your signature failing repeated argument regarding Godot.


Mattstafford910/26/22, 12:53 PM
$ONCY Johnny you are a fool pumper I am reporting you. I have done nothing except lay out the case for why this overhyped junk is t going anywhere
4
 
Mattstafford910/26/22, 12:24 PM
$ONCY not mocking anything just saying this is what everyone is bragging about. If you are gonna die and this stupid drug gives you another month or two. I know I would say F- it. This isn’t a cure for cancer. It’s a just shuffling deck chairs on the titanic. That’s why we sit at 1.30. You guys keep talking like this drug is a big deal. In reality it’s piss
 
Mattstafford910/26/22, 12:19 PM
$ONCY the problem with This stock is that pela is not that effective. Hey folks Joe died in 5 months instead of 3. That’s what you all are bragging about and that’s why we are up a penny down a penny
 
Mattstafford910/26/22, 09:19 AM
$ONCY epic runs are not hidden. If we had big news coming the stock would be jumping. It not doing Jack like it hasn’t for the last 20 years. It’s just Matt’s personal candy store
5

Mattstafford910/26/22, 12:53 PM
$ONCY Johnny you are a fool pumper I am reporting you. I have done nothing except lay out the case for why this overhyped junk is t going anywhere
 
Mattstafford910/26/22, 12:24 PM
$ONCY not mocking anything just saying this is what everyone is bragging about. If you are gonna die and this stupid drug gives you another month or two. I know I would say F- it. This isn’t a cure for cancer. It’s a just shuffling deck chairs on the titanic. That’s why we sit at 1.30. You guys keep talking like this drug is a big deal. In reality it’s piss
 
Mattstafford910/26/22, 12:19 PM
$ONCY the problem with This stock is that pela is not that effective. Hey folks Joe died in 5 months instead of 3. That’s what you all are bragging about and that’s why we are up a penny down a penny
 
Mattstafford910/26/22, 09:19 AM
$ONCY epic runs are not hidden. If we had big news coming the stock would be jumping. It not doing Jack like it hasn’t for the last 20 years. It’s just Matt’s personal candy store

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities